Prednisone Recruiting Phase 2 / 3 Trials for Lymphoma, Large B-Cell, Diffuse (DLBCL) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT03536039RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor
NCT03758989A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma
NCT04025593Biomarker Guided Treatment in DLBCL
NCT02734771A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
NCT02753647Chidamide Plus R-CHOP in Elderly DLBCL